Allspring Global Investments Holdings, LLC
Position in ASND — Ascendis Pharma A/S
CIK 1890906
CHARLOTTE, NC
Position in ASND
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$42,137,554
+$2,124,776 QoQ
Shares Held
184,224
-1.8% QoQ
Ownership
0.281%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
17 quarters on record
Voting authority
Sole 41.18355914538822.ToString("F0")%
Shared 0.ToString("F0")%
None 58.81644085461177.ToString("F0")%
Common Shares in ASND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Allspring Global Investments Holdings, LLC holds $702,720,315 across 64 Biotechnology names. ASND ranks #7 (6.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
175,311 | $128,020,857 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
281,793 | $93,236,848 | |
| 3 | EXEL |
Exelixis, Inc.
|
1,707,715 | $73,243,895 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
889,356 | $66,043,575 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
123,760 | $55,263,790 | |
| 6 | INSM |
INSMED Inc
|
282,734 | $46,232,662 | |
| 7 | ASND |
Ascendis Pharma A/S
This page
|
184,224 | $42,137,554 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
52,497 | $40,561,281 |
All Filings in ASND
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $42,137,554 | 184,224 | Shares | Other | 2026-05-05 | |
| 2025-12-31 | $40,012,778 | 187,642 | Shares | Other | 2026-01-15 | |
| 2025-09-30 | $38,106,309 | 191,672 | Shares | Other | 2025-10-20 | |
| 2025-06-30 | $34,564,357 | 200,257 | Shares | Other | 2025-07-25 | |
| 2025-03-31 | $29,553,081 | 189,613 | Shares | Other | 2025-04-24 | |
| 2024-12-31 | $21,027,438 | 152,738 | Shares | Other | 2025-01-29 | |
| 2024-09-30 | $24,100,125 | 161,410 | Shares | Defined | 2024-10-18 | |
| 2024-06-30 | $24,446,386 | 179,252 | Shares | Defined | 2024-07-26 | |
| 2024-03-31 | $28,602,572 | 189,208 | Shares | Defined | 2024-04-29 | |
| 2023-12-31 | $25,589,512 | 203,172 | Shares | Defined | 2024-01-25 | |
| 2023-09-30 | $19,944,851 | 212,995 | Shares | Defined | 2023-10-27 | |
| 2023-03-31 | $25,755,850 | 240,215 | Shares | Defined | 2023-04-13 | |
| 2022-12-31 | $30,602,112 | 250,570 | Shares | Defined | 2023-01-23 | |
| 2022-09-30 | $26,427,123 | 255,928 | Shares | Defined | 2022-10-26 | |
| 2022-06-30 | $24,514,387 | 263,709 | Shares | Defined | 2022-07-25 | |
| 2022-03-31 | $32,385,843 | 275,953 | Shares | Defined | 2022-04-27 | |
| 2021-12-31 | $37,123,955 | 275,953 | Shares | Defined | 2022-01-28 | |
| No filing history on record for this holder in this stock. | ||||||